对补充剂32的反应基因通过高FoxM1表达促进乳腺癌中的细胞增殖和他莫西芬耐药性
Xinlei Li1, Yan Liu2, Zhiqian Wang3
1Medical College of Qingdao University, Qingdao, China.
PloS one
|July 28, 2025
概括
响应基因对补充 (RGC) -32在乳腺癌中升高,通过激活PI3K/ERα信号和FoxM1.1来驱动他莫西芬耐药性. 向RGC-32可能会在ER+乳腺癌中克服内分泌抵抗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 雌激素受体阳性 (ER+) 乳腺癌往往会对内分泌疗法产生耐药性,这是一个重大的临床挑战.
- 获得的耐药性限制了像他莫西芬这样的治疗方法的长期疗效.
研究的目的:
- 研究RGC-32对ER+乳腺癌内分泌耐药性的作用.
- 阐明RGC-32介导的他莫西芬耐药性的基础分子机制.
主要方法:
- 在乳腺癌组织中RGC-32表达的定量分析.
- 在体外研究涉及RGC-32的过度表达和乳腺癌细胞系的淘汰.
- 评估他莫西芬的敏感性,PI3K/ERα信号传递,以及FoxM1的表达.
主要成果:
- 乳腺癌中RGC-32的表达上调,与预后不佳相关.
- 过度表达RGC-32会诱导他莫西芬耐药性;其降低会恢复敏感性.
- RGC-32激活PI3K通路,增强雌激素受体α (ERα) 活性,这对于FoxM1表达至关重要.
结论:
- 在ER+乳腺癌中,RGC-32是他莫西芬耐药性的关键媒介.
- 准RGC-32是一个潜在的策略来克服获得的内分泌抵抗.
- 抑制RGC-32可以为治疗耐药乳腺癌提供一种补充治疗方法.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K


